Skip to the page

Data / Drug companies / Elixir Healthcare USA, LLC.

Elixir Healthcare USA, LLC.: 8 products in the FDA NDC directory, labeler code 84546

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Elixir Healthcare USA, LLC. (labeler code 84546) lists 8 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 8 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 31, 2025.

The request: Watch Elixir Healthcare USA, LLC. (FDA labeler code 84546): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84546
Products in commercial distribution
8
Packages
16
Finished drugs by generic name
7
Prescription products
0
Over the counter products
8
Flagged as original packager
8 of 8 products that carry the flag
Started marketing in the last 12 months
7
Earliest marketing start
November 1, 2025
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs8100%

Products by type

TypeProductsShare
Over the counter drugs8100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lidocaine 5% cream11
Clotrimazole198
Bacitracin zinc neomycin sulfate polymyxin b12
Hydrocortisone1171
Miconazole nitrate cream11
Zinc oxide 20%110
Bacitracin zinc139

Dosage forms

Dosage formProductsShare
Cream562.5%
Ointment337.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
ElixirTripleGuard Triple Antibiotic84546-0007CreamOver the counter monograph drugsDecember 31, 2025
ElixirCortiRelief84546-0005CreamOver the counter monograph drugsDecember 31, 2025
ElixirZincoCare84546-0004OintmentOver the counter monograph drugsDecember 31, 2025
ElixirTripleGuard Triple Antibiotic84546-0001OintmentOver the counter monograph drugsDecember 24, 2025
ElixirCurozole84546-0003CreamOver the counter monograph drugsDecember 15, 2025
ElixirLidoFast84546-0010CreamOver the counter monograph drugsDecember 1, 2025
ElixirLidoFast Rapid Relief84546-0006CreamOver the counter monograph drugsDecember 1, 2025
ElixirBaciShield First Aid84546-0002OintmentOver the counter monograph drugsNovember 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.